No MI, Mortality Threat From Echo Contrast Agents in Meta-Analysis
Fri, 2010-08-13 23:27 — Anonymous
The study suggests that the perflutren-containing contrast agents present no untoward risk that justifies restrictions on their current indications, researchers say. Heartwire